Likewise, in vivo studies have shown that liraglutide helps prevent abnormalities in Akt and GSK-3β signaling and reduces tau phosphorylation associated with Alzheimer’s disease in the brains of diabetic mice [30,31]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.